Literature DB >> 31233589

Lambert-Eaton myasthenic syndrome and merkel cell carcinoma.

Nam D Nguyen1, Daniel B Simmons2, Adrian R Bersabe3, Thomas M Duginski2, John H Sladky2, Douglas Walton4, Micah Will4, John S Renshaw3.   

Abstract

Lambert-Eaton myasthenic syndrome (LEMS) is an antibody-mediated disorder of the neuromuscular junction that is most commonly diagnosed in association with small cell lung carcinoma (SCLC). Small cell lung carcinoma is histologically similar to the aggressive cutaneous neuroendocrine malignancy Merkel cell carcinoma (MCC). We provide a full report and longitudinal clinical follow-up of a case of LEMS occurring with MCC. We also review the literature on paraneoplastic syndromes associated with MCC and other nonpulmonary small cell carcinomas.

Entities:  

Mesh:

Year:  2019        PMID: 31233589

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  3 in total

Review 1.  Subacute sensory neuronopathy associated with Merkel cell carcinoma with unknown primary: a case report with literature review.

Authors:  Riccardo Milani; Miryam Cannizzaro; Gianluigi Arrigoni; Federica Filipello; Federica Cerri; Massimo Filippi
Journal:  J Neurol       Date:  2022-04-16       Impact factor: 6.682

2.  Lambert-Eaton Myasthenic Syndrome and Paraneoplastic Cerebellar Degeneration Associated with Merkel Cell Carcinoma with Unknown Primary: A Case Report.

Authors:  Andrea Agostini; Martina Merli; Gianluca Avallone; Lorenza Burzi; Luca Mastorino; Mattia Parisi; Davide Bertuzzo; Bruno Ferrero; Marzia Cerrato; Serena Badellino; Luca Molinaro; Leonardo Lopiano; Simone Ribero; Pietro Quaglino
Journal:  Acta Derm Venereol       Date:  2021-05-10       Impact factor: 3.875

3.  The European Lambert-Eaton Myasthenic Syndrome Registry: Long-Term Outcomes Following Symptomatic Treatment.

Authors:  Andreas Meisel; Jörn P Sieb; Gwendal Le Masson; Ville Postila; Sabrina Sacconi
Journal:  Neurol Ther       Date:  2022-05-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.